Skip to main content
    A

    Alignment Healthcare LLC (ALHC)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NASDAQ

    $7.34
    -0.22 (-2.91%)

    Market Cap: $1.58B

    Last updated: Nov 06, 2026 at 4:42 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    75%(18/24)
    Avg Surprise
    +117.16%
    Streak
    8 Q

    Upcoming Estimates

    Period ending Dec 31, 2026
    EPS Consensus$-0.06
    Range$-0.06 - $-0.06
    1 analysts
    Revenue Consensus
    $1.4B
    Range$1.4B - $1.4B
    13 analysts
    Period ending Mar 31, 2027
    EPS Consensus$0.17
    Range$0.15 - $0.18
    2 analysts
    EPS RevisionsNo revisions (7d)No revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.19-14.6%
    60d ago$0.19-14.6%
    30d ago$0.19-14.6%
    7d ago$0.18-10.8%
    Current$0.17
    Revenue Consensus
    $1.6B
    Range$1.5B - $1.6B
    7 analysts
    Last 12 of 27 reported quarters and 2 upcoming estimates
    PeriodReportedEst.RangeSurpriseB/MAnalystsRevisionsYoY
    Mar 27EST
    		-$0.17$0.15 - $0.18--2
    No revisions (30d)
    		-
    Dec 26EST
    		-$-0.06$-0.06 - $-0.06--1--
    Sep 26
    Reported Oct 29
    		$-0.04$-0.04$-0.06 - $-0.02+0.00%Beat4
    No revisions (30d)
    		-140.0%
    Jun 26
    Reported Jul 30
    		$0.17$0.13$0.12 - $0.14+30.77%Beat4
    No revisions (30d)
    		+21.4%
    Mar 26
    Reported Apr 30
    		$0.12$0.09$0.07 - $0.10+33.33%Beat4
    No revisions (30d)
    		+200.0%
    Dec 25
    Reported Feb 26
    		$-0.05N/A-+66.67%Beat4
    1
    1
    30d
    		+12.3%
    Sep 25
    Reported Oct 30
    		$0.10$-0.01$-0.03 - $0.00+1100.00%Beat4
    0
    2
    30d
    		+171.4%
    Jun 25
    Reported Jul 30
    		$0.14$0.01$-0.08 - $0.02+1300.00%Beat6
    0
    2
    30d
    		+566.7%
    Mar 25
    Reported May 1
    		$0.04$-0.04$-0.18 - $-0.03+200.00%Beat5
    1
    0
    30d
    		+133.3%
    Dec 24
    Reported Feb 27
    		$-0.06$-0.08$-0.09 - $-0.08+32.14%Beat5
    No revisions (30d)
    		+77.2%
    Sep 24
    Reported Oct 29
    		$-0.14$-0.08$-0.10 - $-0.05-75.00%Miss10
    No revisions (30d)
    		+22.2%
    Jun 24
    Reported Aug 1
    		$-0.03N/A-+62.50%Beat9
    No revisions (30d)
    		+57.1%
    Mar 24
    Reported May 2
    		$-0.12$-0.16$-0.26 - $-0.14+25.00%Beat11
    0
    1
    30d
    		-50.0%
    Dec 23
    Reported Feb 27
    		$-0.25$-0.22$-0.25 - $-0.19-13.64%Miss9
    No revisions (30d)
    		+19.4%

    Key Metrics

    Valuation
    P/E Ratio36.70EV/EBITDA13.02x
    Price/FCF8.58xFCF Yield11.66%
    Profitability
    Profit Margin0.59%Operating Margin-0.28%
    ROE13.20%ROIC9.34%
    Financial Health
    Debt/Equity1.22xInterest Coverage3.39x
    Current Ratio1.70xQuick Ratio1.70x
    Trading Statistics
    Beta1.04Avg Volume7.40M
    52-Week High$25.1252-Week Low$6.01

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$7.69
    SMA 20$7.99
    SMA 50$9.27
    SMA 200$16.42
    EMA 10$7.69
    EMA 20$7.98
    EMA 50$9.55
    EMA 200$14.48

    MACD

    Line: -0.47Signal: -0.53Hist: 0.05

    ADX

    ADX: 32.6+DI: 21.8-DI: 29.6

    Aroon & PSAR

    Aroon Up12.0
    Aroon Down20.0
    PSAR$6.93

    Bollinger Bands

    Upper Band$8.87
    Lower Band$7.11
    %B Position2196%(Upper)
    Band Width0.13

    RSI (14-Day)

    Neutral
    39.3

    Momentum Oscillators

    Stoch %K44.6
    Stoch %D41.5
    Williams %R-74.9
    ROC (10d)-8.9%
    Momentum-0.72
    CCI (20d)-138.1
    MFI (14d)43.4

    Volatility Measures

    ATR (14d)$0.60(8.2%)
    StdDev (20d)0.44
    Hist Vol73.1%(High)

    Volume Flow

    VWAP$7.37
    OBV-211.2M
    AD Line-46.7M
    CMF (20d)-0.143

    Volume Metrics

    Avg Vol (20d)6.3M
    Vol Ratio0.6x
    VWMA (20d)$7.92

    Pivot Points

    R3$9.30
    R2$8.93
    R1$8.24
    Pivot Point$7.87
    S1$7.18
    S2$6.81
    S3$6.12

    Advanced Oscillators

    TSI-22.38
    Ultimate Osc39.0
    KST-117.09

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.34B$1.24B$1.01B$993.70M$1.02B$926.93M$701.24M$692.43M$681.29M$628.60M$465.39M$456.71M
    Cost of Revenue$0$0$889.49M$0$0$0$614.90M$0$0$0$417.76M$0
    Gross Profit$1.34B$1.24B$1.01B$993.70M$1.02B$926.93M$701.24M$692.43M$681.29M$628.60M$465.39M$456.71M
    Operating Expenses$1.29B$1.22B$1.02B$986.01M$992.54M$932.33M$723.79M$711.96M$699.67M$669.71M$507.30M$486.46M
    R&D$0$0$0$0$0$0$0$0$0$0$0$0
    SG&A$131.00M$121.14M$125.76M$110.02M$103.80M$103.83M$102.13M$90.87M$87.86M$90.51M$83.74M$83.09M
    Operating Income$42.10M$15.50M$-10,284,000$7.68M$22.75M$-5,393,000$-22,545,000$-19,522,000$-18,382,000$-41,106,000$-41,913,000$-29,756,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$4.28M$4.06M$3.95M$3.95M$3.95M$3.95M$8.51M$6.94M$5.69M$5.43M$5.48M$5.47M
    Income Before Tax$37.83M$11.44M$-14,233,000$3.73M$18.88M$-9,333,000$-31,057,000$-26,437,000$-23,981,000$-46,575,000$-47,255,000$-35,077,000
    Income Tax Expense$1.27M$25,000$-3,227,000$2,000$3.22M$21,000$7,000$-8,000$22,000$0$-24,000$0
    Net Income$36.56M$11.42M$-11,006,000$3.73M$15.65M$-9,354,000$-31,064,000$-26,429,000$-24,003,000$-46,575,000$-47,231,000$-35,077,000
    EBITDA$50.60M$23.87M$-2,010,000$16.11M$30.30M$2.68M$-15,422,000$-11,448,000$-11,659,000$-34,599,000$-35,835,000$-23,892,000
    EBIT$42.10M$15.50M$-10,284,000$7.68M$22.83M$-5,383,000$-22,545,000$-19,500,000$-18,290,000$-41,148,000$-41,913,000$-29,756,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ALHC

    News

    Is Alignment Healthcare (ALHC) Undervalued After Raised Guidance And A Quarterly Loss?

    Alignment Healthcare (ALHC) recently reported third-quarter results with higher revenue but a net loss, subsequently raising its full-year sales and membership guidance. This has led to a recent jump in its share price...

    Simply Wall St•11/3/26•Neutral

    ALHC Shareholder Notice: Alignment Healthcare Under Investigation for Potential Securities Fraud over Alleged Misrepresentations to Investors

    Bleichmar Fonti & Auld LLP has announced an investigation into Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities fraud. The investigation stems from allegations that Alignment artificially inflated its...

    PR Newswire•11/3/26•Bearish

    ALHC Shareholder Notice: Alignment Healthcare Under Investigation for Potential Securities Fraud over Alleged Misrepresentations to Investors

    Bleichmar Fonti & Auld LLP is investigating Alignment Healthcare, Inc. (NASDAQ: ALHC) for potential securities fraud. The investigation stems from allegations that the company artificially inflated its adjusted EBITDA by...

    Morningstar•11/3/26•Bearish

    US$10.96: That's What Analysts Think Alignment Healthcare, Inc. (NASDAQ:ALHC) Is Worth After Its Latest Results

    Alignment Healthcare, Inc. (NASDAQ:ALHC) recently reported its third-quarter results, exceeding revenue forecasts but leading to a 9.8% drop in share price. Analysts have since revised their earnings per share estimates...

    Simply Wall St•11/1/26•Somewhat-Bearish

    UBS maintains Alignment Healthcare at Neutral, lowers price target to $8 from $9

    UBS has reiterated its "Neutral" rating for Alignment Healthcare (ALHC) but reduced its price target to $8 from $9...

    TradingView•10/31/26•Somewhat-Bearish

    ALHC Valuation and Fair Value

    P/E
    36.7x
    Forward P/E
    204.1x
    EV/EBITDA
    13.0x
    P/FCF
    8.6x
    P/B
    5.7x
    See GNG's fair value

    ALHC Profitability: Margins, ROIC and FCF

    Gross margin
    100.0%
    Operating margin
    -0.3%
    Net margin
    0.6%
    ROIC
    9.3%
    ROE
    13.2%
    FCF margin
    3.9%
    FCF yield
    11.7%

    ALHC Competitors

    CompanyTicker
    UltragenyxRARE
    CONMED CorporationCNMD
    Sellas Life Sciences Group IncSLS
    Ocular Therapeutix IncOCUL
    Novavax IncNVAX
    RAPT Therapeutics IncRAPT
    Nurix Therapeutics IncNRIX
    Supernus Pharmaceuticals, Inc.SUPN

    Sector: Healthcare

    ALHC Analyst Ratings

    Consensus
    Buy
    Analysts
    15
    Strong Buy
    3
    Buy
    6
    Hold
    6
    Sell
    0
    Strong Sell
    0

    ALHC Bull Case vs Bear Case

    Bull case

    • ALHC beat EPS estimates in 87.5% of its last 8 reported quarters.
    • ALHC grew quarterly revenue 36.7% year over year.
    • 60.0% of ALHC's analyst ratings are Buy or Strong Buy.

    ALHC Earnings: Beat Rate and Next Report

    Beat rate
    7 of 8 quarters (87.5%)
    Average surprise
    345.4%
    EPS estimate (fiscal period ending Dec 31, 2026)
    $-0.06

    ALHC Earnings Date

    ALHC reports Feb 24, 2027, after the close. The date is estimated.

    ALHC Earnings Call

    The latest ALHC earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    ALHC ETF Holders

    GNG tracks 14 ETFs that hold ALHC. The largest weights:

    1. First Trust Small Cap Growth AlphaDEX Fund (FYC), 0.13% of the fund
    2. Vanguard Russell 2000 Index Fund ETF Shares (VTWO), 0.10% of the fund
    3. iShares Core S&P Small-Cap ETF (IJR), 0.09% of the fund
    4. iShares Russell 2000 ETF (IWM), 0.07% of the fund
    5. Fidelity Enhanced Small Cap Core ETF (FESM), 0.06% of the fund
    Open the ETF Stock Exposure tool for ALHC

    See insider activity

    Frequently Asked Questions About ALHC

    When does ALHC report earnings?

    Alignment Healthcare LLC (ALHC) is expected to report earnings on Feb 24, 2027.

    Does ALHC pay dividends?

    Alignment Healthcare LLC (ALHC) does not currently pay a regular dividend.

    What is ALHC's P/E ratio?

    Alignment Healthcare LLC has a price-to-earnings (P/E) ratio of 36.70.

    What is ALHC's market cap?

    Alignment Healthcare LLC (ALHC) has a market capitalization of $1.58B with a current stock price of $7.34.

    Related stocks

    Sector: Healthcare

    All stocks starting with A

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In